Global Pharma Sustained Release Excipient Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Pharma Sustained Release Excipient market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharma Sustained Release Excipient Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharma Sustained Release Excipient market in any manner.
Global Pharma Sustained Release Excipient Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Market Segmentation (by Type)
Gelatin
Polymers
Minerals
Sugars
Chitosan
Market Segmentation (by Application)
Pharmaceutical
Health Care
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharma Sustained Release Excipient Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Pharma Sustained Release Excipient market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharma Sustained Release Excipient Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharma Sustained Release Excipient market in any manner.
Global Pharma Sustained Release Excipient Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Market Segmentation (by Type)
Gelatin
Polymers
Minerals
Sugars
Chitosan
Market Segmentation (by Application)
Pharmaceutical
Health Care
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pharma Sustained Release Excipient Market
- Overview of the regional outlook of the Pharma Sustained Release Excipient Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharma Sustained Release Excipient Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharma Sustained Release Excipient
1.2 Key Market Segments
1.2.1 Pharma Sustained Release Excipient Segment by Type
1.2.2 Pharma Sustained Release Excipient Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharma Sustained Release Excipient Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharma Sustained Release Excipient Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharma Sustained Release Excipient Sales by Manufacturers (2019-2024)
3.2 Global Pharma Sustained Release Excipient Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharma Sustained Release Excipient Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharma Sustained Release Excipient Sales Sites, Area Served, Product Type
3.6 Pharma Sustained Release Excipient Market Competitive Situation and Trends
3.6.1 Pharma Sustained Release Excipient Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharma Sustained Release Excipient Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMA SUSTAINED RELEASE EXCIPIENT INDUSTRY CHAIN ANALYSIS
4.1 Pharma Sustained Release Excipient Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMA SUSTAINED RELEASE EXCIPIENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharma Sustained Release Excipient Sales Market Share by Type (2019-2024)
6.3 Global Pharma Sustained Release Excipient Market Size Market Share by Type (2019-2024)
6.4 Global Pharma Sustained Release Excipient Price by Type (2019-2024)
7 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharma Sustained Release Excipient Market Sales by Application (2019-2024)
7.3 Global Pharma Sustained Release Excipient Market Size (M USD) by Application (2019-2024)
7.4 Global Pharma Sustained Release Excipient Sales Growth Rate by Application (2019-2024)
8 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET SEGMENTATION BY REGION
8.1 Global Pharma Sustained Release Excipient Sales by Region
8.1.1 Global Pharma Sustained Release Excipient Sales by Region
8.1.2 Global Pharma Sustained Release Excipient Sales Market Share by Region
8.2 North America
8.2.1 North America Pharma Sustained Release Excipient Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharma Sustained Release Excipient Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharma Sustained Release Excipient Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharma Sustained Release Excipient Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharma Sustained Release Excipient Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva Pharmaceutical Industries
9.1.1 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
9.1.2 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
9.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Market Performance
9.1.4 Teva Pharmaceutical Industries Business Overview
9.1.5 Teva Pharmaceutical Industries Pharma Sustained Release Excipient SWOT Analysis
9.1.6 Teva Pharmaceutical Industries Recent Developments
9.2 Mylan N.V.
9.2.1 Mylan N.V. Pharma Sustained Release Excipient Basic Information
9.2.2 Mylan N.V. Pharma Sustained Release Excipient Product Overview
9.2.3 Mylan N.V. Pharma Sustained Release Excipient Product Market Performance
9.2.4 Mylan N.V. Business Overview
9.2.5 Mylan N.V. Pharma Sustained Release Excipient SWOT Analysis
9.2.6 Mylan N.V. Recent Developments
9.3 Valeant Pharmaceuticals International
9.3.1 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Basic Information
9.3.2 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Overview
9.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Market Performance
9.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Excipient SWOT Analysis
9.3.5 Valeant Pharmaceuticals International Business Overview
9.3.6 Valeant Pharmaceuticals International Recent Developments
9.4 Pfizer
9.4.1 Pfizer Pharma Sustained Release Excipient Basic Information
9.4.2 Pfizer Pharma Sustained Release Excipient Product Overview
9.4.3 Pfizer Pharma Sustained Release Excipient Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Sun Pharmaceutical Industries
9.5.1 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
9.5.2 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
9.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Market Performance
9.5.4 Sun Pharmaceutical Industries Business Overview
9.5.5 Sun Pharmaceutical Industries Recent Developments
9.6 Novartis AG
9.6.1 Novartis AG Pharma Sustained Release Excipient Basic Information
9.6.2 Novartis AG Pharma Sustained Release Excipient Product Overview
9.6.3 Novartis AG Pharma Sustained Release Excipient Product Market Performance
9.6.4 Novartis AG Business Overview
9.6.5 Novartis AG Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Pharma Sustained Release Excipient Basic Information
9.7.2 AstraZeneca Pharma Sustained Release Excipient Product Overview
9.7.3 AstraZeneca Pharma Sustained Release Excipient Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Pharma Sustained Release Excipient Basic Information
9.8.2 GlaxoSmithKline Pharma Sustained Release Excipient Product Overview
9.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Product Market Performance
9.8.4 GlaxoSmithKline Business Overview
9.8.5 GlaxoSmithKline Recent Developments
9.9 Allergan
9.9.1 Allergan Pharma Sustained Release Excipient Basic Information
9.9.2 Allergan Pharma Sustained Release Excipient Product Overview
9.9.3 Allergan Pharma Sustained Release Excipient Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 Janssen Pharmaceuticals
9.10.1 Janssen Pharmaceuticals Pharma Sustained Release Excipient Basic Information
9.10.2 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Overview
9.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Market Performance
9.10.4 Janssen Pharmaceuticals Business Overview
9.10.5 Janssen Pharmaceuticals Recent Developments
9.11 Mayne Pharma Group
9.11.1 Mayne Pharma Group Pharma Sustained Release Excipient Basic Information
9.11.2 Mayne Pharma Group Pharma Sustained Release Excipient Product Overview
9.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Product Market Performance
9.11.4 Mayne Pharma Group Business Overview
9.11.5 Mayne Pharma Group Recent Developments
9.12 BASF
9.12.1 BASF Pharma Sustained Release Excipient Basic Information
9.12.2 BASF Pharma Sustained Release Excipient Product Overview
9.12.3 BASF Pharma Sustained Release Excipient Product Market Performance
9.12.4 BASF Business Overview
9.12.5 BASF Recent Developments
9.13 International Flavors and Fragrances
9.13.1 International Flavors and Fragrances Pharma Sustained Release Excipient Basic Information
9.13.2 International Flavors and Fragrances Pharma Sustained Release Excipient Product Overview
9.13.3 International Flavors and Fragrances Pharma Sustained Release Excipient Product Market Performance
9.13.4 International Flavors and Fragrances Business Overview
9.13.5 International Flavors and Fragrances Recent Developments
9.14 Ashland Global
9.14.1 Ashland Global Pharma Sustained Release Excipient Basic Information
9.14.2 Ashland Global Pharma Sustained Release Excipient Product Overview
9.14.3 Ashland Global Pharma Sustained Release Excipient Product Market Performance
9.14.4 Ashland Global Business Overview
9.14.5 Ashland Global Recent Developments
9.15 Evonik Industries
9.15.1 Evonik Industries Pharma Sustained Release Excipient Basic Information
9.15.2 Evonik Industries Pharma Sustained Release Excipient Product Overview
9.15.3 Evonik Industries Pharma Sustained Release Excipient Product Market Performance
9.15.4 Evonik Industries Business Overview
9.15.5 Evonik Industries Recent Developments
9.16 Croda International
9.16.1 Croda International Pharma Sustained Release Excipient Basic Information
9.16.2 Croda International Pharma Sustained Release Excipient Product Overview
9.16.3 Croda International Pharma Sustained Release Excipient Product Market Performance
9.16.4 Croda International Business Overview
9.16.5 Croda International Recent Developments
9.17 Gattefosse
9.17.1 Gattefosse Pharma Sustained Release Excipient Basic Information
9.17.2 Gattefosse Pharma Sustained Release Excipient Product Overview
9.17.3 Gattefosse Pharma Sustained Release Excipient Product Market Performance
9.17.4 Gattefosse Business Overview
9.17.5 Gattefosse Recent Developments
9.18 Merck KGaA
9.18.1 Merck KGaA Pharma Sustained Release Excipient Basic Information
9.18.2 Merck KGaA Pharma Sustained Release Excipient Product Overview
9.18.3 Merck KGaA Pharma Sustained Release Excipient Product Market Performance
9.18.4 Merck KGaA Business Overview
9.18.5 Merck KGaA Recent Developments
10 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET FORECAST BY REGION
10.1 Global Pharma Sustained Release Excipient Market Size Forecast
10.2 Global Pharma Sustained Release Excipient Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharma Sustained Release Excipient Market Size Forecast by Country
10.2.3 Asia Pacific Pharma Sustained Release Excipient Market Size Forecast by Region
10.2.4 South America Pharma Sustained Release Excipient Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharma Sustained Release Excipient by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharma Sustained Release Excipient Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharma Sustained Release Excipient by Type (2025-2030)
11.1.2 Global Pharma Sustained Release Excipient Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharma Sustained Release Excipient by Type (2025-2030)
11.2 Global Pharma Sustained Release Excipient Market Forecast by Application (2025-2030)
11.2.1 Global Pharma Sustained Release Excipient Sales (Kilotons) Forecast by Application
11.2.2 Global Pharma Sustained Release Excipient Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharma Sustained Release Excipient
1.2 Key Market Segments
1.2.1 Pharma Sustained Release Excipient Segment by Type
1.2.2 Pharma Sustained Release Excipient Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharma Sustained Release Excipient Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharma Sustained Release Excipient Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharma Sustained Release Excipient Sales by Manufacturers (2019-2024)
3.2 Global Pharma Sustained Release Excipient Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharma Sustained Release Excipient Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharma Sustained Release Excipient Sales Sites, Area Served, Product Type
3.6 Pharma Sustained Release Excipient Market Competitive Situation and Trends
3.6.1 Pharma Sustained Release Excipient Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharma Sustained Release Excipient Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMA SUSTAINED RELEASE EXCIPIENT INDUSTRY CHAIN ANALYSIS
4.1 Pharma Sustained Release Excipient Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMA SUSTAINED RELEASE EXCIPIENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharma Sustained Release Excipient Sales Market Share by Type (2019-2024)
6.3 Global Pharma Sustained Release Excipient Market Size Market Share by Type (2019-2024)
6.4 Global Pharma Sustained Release Excipient Price by Type (2019-2024)
7 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharma Sustained Release Excipient Market Sales by Application (2019-2024)
7.3 Global Pharma Sustained Release Excipient Market Size (M USD) by Application (2019-2024)
7.4 Global Pharma Sustained Release Excipient Sales Growth Rate by Application (2019-2024)
8 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET SEGMENTATION BY REGION
8.1 Global Pharma Sustained Release Excipient Sales by Region
8.1.1 Global Pharma Sustained Release Excipient Sales by Region
8.1.2 Global Pharma Sustained Release Excipient Sales Market Share by Region
8.2 North America
8.2.1 North America Pharma Sustained Release Excipient Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharma Sustained Release Excipient Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharma Sustained Release Excipient Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharma Sustained Release Excipient Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharma Sustained Release Excipient Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva Pharmaceutical Industries
9.1.1 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
9.1.2 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
9.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Market Performance
9.1.4 Teva Pharmaceutical Industries Business Overview
9.1.5 Teva Pharmaceutical Industries Pharma Sustained Release Excipient SWOT Analysis
9.1.6 Teva Pharmaceutical Industries Recent Developments
9.2 Mylan N.V.
9.2.1 Mylan N.V. Pharma Sustained Release Excipient Basic Information
9.2.2 Mylan N.V. Pharma Sustained Release Excipient Product Overview
9.2.3 Mylan N.V. Pharma Sustained Release Excipient Product Market Performance
9.2.4 Mylan N.V. Business Overview
9.2.5 Mylan N.V. Pharma Sustained Release Excipient SWOT Analysis
9.2.6 Mylan N.V. Recent Developments
9.3 Valeant Pharmaceuticals International
9.3.1 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Basic Information
9.3.2 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Overview
9.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Market Performance
9.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Excipient SWOT Analysis
9.3.5 Valeant Pharmaceuticals International Business Overview
9.3.6 Valeant Pharmaceuticals International Recent Developments
9.4 Pfizer
9.4.1 Pfizer Pharma Sustained Release Excipient Basic Information
9.4.2 Pfizer Pharma Sustained Release Excipient Product Overview
9.4.3 Pfizer Pharma Sustained Release Excipient Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Sun Pharmaceutical Industries
9.5.1 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
9.5.2 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
9.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Market Performance
9.5.4 Sun Pharmaceutical Industries Business Overview
9.5.5 Sun Pharmaceutical Industries Recent Developments
9.6 Novartis AG
9.6.1 Novartis AG Pharma Sustained Release Excipient Basic Information
9.6.2 Novartis AG Pharma Sustained Release Excipient Product Overview
9.6.3 Novartis AG Pharma Sustained Release Excipient Product Market Performance
9.6.4 Novartis AG Business Overview
9.6.5 Novartis AG Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Pharma Sustained Release Excipient Basic Information
9.7.2 AstraZeneca Pharma Sustained Release Excipient Product Overview
9.7.3 AstraZeneca Pharma Sustained Release Excipient Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Pharma Sustained Release Excipient Basic Information
9.8.2 GlaxoSmithKline Pharma Sustained Release Excipient Product Overview
9.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Product Market Performance
9.8.4 GlaxoSmithKline Business Overview
9.8.5 GlaxoSmithKline Recent Developments
9.9 Allergan
9.9.1 Allergan Pharma Sustained Release Excipient Basic Information
9.9.2 Allergan Pharma Sustained Release Excipient Product Overview
9.9.3 Allergan Pharma Sustained Release Excipient Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 Janssen Pharmaceuticals
9.10.1 Janssen Pharmaceuticals Pharma Sustained Release Excipient Basic Information
9.10.2 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Overview
9.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Market Performance
9.10.4 Janssen Pharmaceuticals Business Overview
9.10.5 Janssen Pharmaceuticals Recent Developments
9.11 Mayne Pharma Group
9.11.1 Mayne Pharma Group Pharma Sustained Release Excipient Basic Information
9.11.2 Mayne Pharma Group Pharma Sustained Release Excipient Product Overview
9.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Product Market Performance
9.11.4 Mayne Pharma Group Business Overview
9.11.5 Mayne Pharma Group Recent Developments
9.12 BASF
9.12.1 BASF Pharma Sustained Release Excipient Basic Information
9.12.2 BASF Pharma Sustained Release Excipient Product Overview
9.12.3 BASF Pharma Sustained Release Excipient Product Market Performance
9.12.4 BASF Business Overview
9.12.5 BASF Recent Developments
9.13 International Flavors and Fragrances
9.13.1 International Flavors and Fragrances Pharma Sustained Release Excipient Basic Information
9.13.2 International Flavors and Fragrances Pharma Sustained Release Excipient Product Overview
9.13.3 International Flavors and Fragrances Pharma Sustained Release Excipient Product Market Performance
9.13.4 International Flavors and Fragrances Business Overview
9.13.5 International Flavors and Fragrances Recent Developments
9.14 Ashland Global
9.14.1 Ashland Global Pharma Sustained Release Excipient Basic Information
9.14.2 Ashland Global Pharma Sustained Release Excipient Product Overview
9.14.3 Ashland Global Pharma Sustained Release Excipient Product Market Performance
9.14.4 Ashland Global Business Overview
9.14.5 Ashland Global Recent Developments
9.15 Evonik Industries
9.15.1 Evonik Industries Pharma Sustained Release Excipient Basic Information
9.15.2 Evonik Industries Pharma Sustained Release Excipient Product Overview
9.15.3 Evonik Industries Pharma Sustained Release Excipient Product Market Performance
9.15.4 Evonik Industries Business Overview
9.15.5 Evonik Industries Recent Developments
9.16 Croda International
9.16.1 Croda International Pharma Sustained Release Excipient Basic Information
9.16.2 Croda International Pharma Sustained Release Excipient Product Overview
9.16.3 Croda International Pharma Sustained Release Excipient Product Market Performance
9.16.4 Croda International Business Overview
9.16.5 Croda International Recent Developments
9.17 Gattefosse
9.17.1 Gattefosse Pharma Sustained Release Excipient Basic Information
9.17.2 Gattefosse Pharma Sustained Release Excipient Product Overview
9.17.3 Gattefosse Pharma Sustained Release Excipient Product Market Performance
9.17.4 Gattefosse Business Overview
9.17.5 Gattefosse Recent Developments
9.18 Merck KGaA
9.18.1 Merck KGaA Pharma Sustained Release Excipient Basic Information
9.18.2 Merck KGaA Pharma Sustained Release Excipient Product Overview
9.18.3 Merck KGaA Pharma Sustained Release Excipient Product Market Performance
9.18.4 Merck KGaA Business Overview
9.18.5 Merck KGaA Recent Developments
10 PHARMA SUSTAINED RELEASE EXCIPIENT MARKET FORECAST BY REGION
10.1 Global Pharma Sustained Release Excipient Market Size Forecast
10.2 Global Pharma Sustained Release Excipient Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharma Sustained Release Excipient Market Size Forecast by Country
10.2.3 Asia Pacific Pharma Sustained Release Excipient Market Size Forecast by Region
10.2.4 South America Pharma Sustained Release Excipient Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharma Sustained Release Excipient by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharma Sustained Release Excipient Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharma Sustained Release Excipient by Type (2025-2030)
11.1.2 Global Pharma Sustained Release Excipient Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharma Sustained Release Excipient by Type (2025-2030)
11.2 Global Pharma Sustained Release Excipient Market Forecast by Application (2025-2030)
11.2.1 Global Pharma Sustained Release Excipient Sales (Kilotons) Forecast by Application
11.2.2 Global Pharma Sustained Release Excipient Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharma Sustained Release Excipient Market Size Comparison by Region (M USD)
Table 5. Global Pharma Sustained Release Excipient Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharma Sustained Release Excipient Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2022)
Table 10. Global Market Pharma Sustained Release Excipient Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharma Sustained Release Excipient Sales Sites and Area Served
Table 12. Manufacturers Pharma Sustained Release Excipient Product Type
Table 13. Global Pharma Sustained Release Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharma Sustained Release Excipient
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharma Sustained Release Excipient Market Challenges
Table 22. Global Pharma Sustained Release Excipient Sales by Type (Kilotons)
Table 23. Global Pharma Sustained Release Excipient Market Size by Type (M USD)
Table 24. Global Pharma Sustained Release Excipient Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pharma Sustained Release Excipient Sales Market Share by Type (2019-2024)
Table 26. Global Pharma Sustained Release Excipient Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharma Sustained Release Excipient Market Size Share by Type (2019-2024)
Table 28. Global Pharma Sustained Release Excipient Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pharma Sustained Release Excipient Sales (Kilotons) by Application
Table 30. Global Pharma Sustained Release Excipient Market Size by Application
Table 31. Global Pharma Sustained Release Excipient Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pharma Sustained Release Excipient Sales Market Share by Application (2019-2024)
Table 33. Global Pharma Sustained Release Excipient Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharma Sustained Release Excipient Market Share by Application (2019-2024)
Table 35. Global Pharma Sustained Release Excipient Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pharma Sustained Release Excipient Sales Market Share by Region (2019-2024)
Table 38. North America Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
Table 44. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
Table 45. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Pharmaceutical Industries Business Overview
Table 47. Teva Pharmaceutical Industries Pharma Sustained Release Excipient SWOT Analysis
Table 48. Teva Pharmaceutical Industries Recent Developments
Table 49. Mylan N.V. Pharma Sustained Release Excipient Basic Information
Table 50. Mylan N.V. Pharma Sustained Release Excipient Product Overview
Table 51. Mylan N.V. Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Mylan N.V. Business Overview
Table 53. Mylan N.V. Pharma Sustained Release Excipient SWOT Analysis
Table 54. Mylan N.V. Recent Developments
Table 55. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Basic Information
Table 56. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Overview
Table 57. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Valeant Pharmaceuticals International Pharma Sustained Release Excipient SWOT Analysis
Table 59. Valeant Pharmaceuticals International Business Overview
Table 60. Valeant Pharmaceuticals International Recent Developments
Table 61. Pfizer Pharma Sustained Release Excipient Basic Information
Table 62. Pfizer Pharma Sustained Release Excipient Product Overview
Table 63. Pfizer Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
Table 67. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
Table 68. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sun Pharmaceutical Industries Business Overview
Table 70. Sun Pharmaceutical Industries Recent Developments
Table 71. Novartis AG Pharma Sustained Release Excipient Basic Information
Table 72. Novartis AG Pharma Sustained Release Excipient Product Overview
Table 73. Novartis AG Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Recent Developments
Table 76. AstraZeneca Pharma Sustained Release Excipient Basic Information
Table 77. AstraZeneca Pharma Sustained Release Excipient Product Overview
Table 78. AstraZeneca Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. GlaxoSmithKline Pharma Sustained Release Excipient Basic Information
Table 82. GlaxoSmithKline Pharma Sustained Release Excipient Product Overview
Table 83. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Recent Developments
Table 86. Allergan Pharma Sustained Release Excipient Basic Information
Table 87. Allergan Pharma Sustained Release Excipient Product Overview
Table 88. Allergan Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Allergan Business Overview
Table 90. Allergan Recent Developments
Table 91. Janssen Pharmaceuticals Pharma Sustained Release Excipient Basic Information
Table 92. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Overview
Table 93. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Janssen Pharmaceuticals Business Overview
Table 95. Janssen Pharmaceuticals Recent Developments
Table 96. Mayne Pharma Group Pharma Sustained Release Excipient Basic Information
Table 97. Mayne Pharma Group Pharma Sustained Release Excipient Product Overview
Table 98. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mayne Pharma Group Business Overview
Table 100. Mayne Pharma Group Recent Developments
Table 101. BASF Pharma Sustained Release Excipient Basic Information
Table 102. BASF Pharma Sustained Release Excipient Product Overview
Table 103. BASF Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BASF Business Overview
Table 105. BASF Recent Developments
Table 106. International Flavors and Fragrances Pharma Sustained Release Excipient Basic Information
Table 107. International Flavors and Fragrances Pharma Sustained Release Excipient Product Overview
Table 108. International Flavors and Fragrances Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. International Flavors and Fragrances Business Overview
Table 110. International Flavors and Fragrances Recent Developments
Table 111. Ashland Global Pharma Sustained Release Excipient Basic Information
Table 112. Ashland Global Pharma Sustained Release Excipient Product Overview
Table 113. Ashland Global Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ashland Global Business Overview
Table 115. Ashland Global Recent Developments
Table 116. Evonik Industries Pharma Sustained Release Excipient Basic Information
Table 117. Evonik Industries Pharma Sustained Release Excipient Product Overview
Table 118. Evonik Industries Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Evonik Industries Business Overview
Table 120. Evonik Industries Recent Developments
Table 121. Croda International Pharma Sustained Release Excipient Basic Information
Table 122. Croda International Pharma Sustained Release Excipient Product Overview
Table 123. Croda International Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Croda International Business Overview
Table 125. Croda International Recent Developments
Table 126. Gattefosse Pharma Sustained Release Excipient Basic Information
Table 127. Gattefosse Pharma Sustained Release Excipient Product Overview
Table 128. Gattefosse Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Gattefosse Business Overview
Table 130. Gattefosse Recent Developments
Table 131. Merck KGaA Pharma Sustained Release Excipient Basic Information
Table 132. Merck KGaA Pharma Sustained Release Excipient Product Overview
Table 133. Merck KGaA Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Merck KGaA Business Overview
Table 135. Merck KGaA Recent Developments
Table 136. Global Pharma Sustained Release Excipient Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Pharma Sustained Release Excipient Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Pharma Sustained Release Excipient Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Pharma Sustained Release Excipient Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Pharma Sustained Release Excipient Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Pharma Sustained Release Excipient Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Pharma Sustained Release Excipient Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Pharma Sustained Release Excipient Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Pharma Sustained Release Excipient Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Pharma Sustained Release Excipient Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Pharma Sustained Release Excipient Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Pharma Sustained Release Excipient Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Pharma Sustained Release Excipient Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharma Sustained Release Excipient Market Size Comparison by Region (M USD)
Table 5. Global Pharma Sustained Release Excipient Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharma Sustained Release Excipient Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2022)
Table 10. Global Market Pharma Sustained Release Excipient Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharma Sustained Release Excipient Sales Sites and Area Served
Table 12. Manufacturers Pharma Sustained Release Excipient Product Type
Table 13. Global Pharma Sustained Release Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharma Sustained Release Excipient
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharma Sustained Release Excipient Market Challenges
Table 22. Global Pharma Sustained Release Excipient Sales by Type (Kilotons)
Table 23. Global Pharma Sustained Release Excipient Market Size by Type (M USD)
Table 24. Global Pharma Sustained Release Excipient Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pharma Sustained Release Excipient Sales Market Share by Type (2019-2024)
Table 26. Global Pharma Sustained Release Excipient Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharma Sustained Release Excipient Market Size Share by Type (2019-2024)
Table 28. Global Pharma Sustained Release Excipient Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pharma Sustained Release Excipient Sales (Kilotons) by Application
Table 30. Global Pharma Sustained Release Excipient Market Size by Application
Table 31. Global Pharma Sustained Release Excipient Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pharma Sustained Release Excipient Sales Market Share by Application (2019-2024)
Table 33. Global Pharma Sustained Release Excipient Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharma Sustained Release Excipient Market Share by Application (2019-2024)
Table 35. Global Pharma Sustained Release Excipient Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pharma Sustained Release Excipient Sales Market Share by Region (2019-2024)
Table 38. North America Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
Table 44. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
Table 45. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Pharmaceutical Industries Business Overview
Table 47. Teva Pharmaceutical Industries Pharma Sustained Release Excipient SWOT Analysis
Table 48. Teva Pharmaceutical Industries Recent Developments
Table 49. Mylan N.V. Pharma Sustained Release Excipient Basic Information
Table 50. Mylan N.V. Pharma Sustained Release Excipient Product Overview
Table 51. Mylan N.V. Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Mylan N.V. Business Overview
Table 53. Mylan N.V. Pharma Sustained Release Excipient SWOT Analysis
Table 54. Mylan N.V. Recent Developments
Table 55. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Basic Information
Table 56. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Overview
Table 57. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Valeant Pharmaceuticals International Pharma Sustained Release Excipient SWOT Analysis
Table 59. Valeant Pharmaceuticals International Business Overview
Table 60. Valeant Pharmaceuticals International Recent Developments
Table 61. Pfizer Pharma Sustained Release Excipient Basic Information
Table 62. Pfizer Pharma Sustained Release Excipient Product Overview
Table 63. Pfizer Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Basic Information
Table 67. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Overview
Table 68. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sun Pharmaceutical Industries Business Overview
Table 70. Sun Pharmaceutical Industries Recent Developments
Table 71. Novartis AG Pharma Sustained Release Excipient Basic Information
Table 72. Novartis AG Pharma Sustained Release Excipient Product Overview
Table 73. Novartis AG Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Recent Developments
Table 76. AstraZeneca Pharma Sustained Release Excipient Basic Information
Table 77. AstraZeneca Pharma Sustained Release Excipient Product Overview
Table 78. AstraZeneca Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. GlaxoSmithKline Pharma Sustained Release Excipient Basic Information
Table 82. GlaxoSmithKline Pharma Sustained Release Excipient Product Overview
Table 83. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Recent Developments
Table 86. Allergan Pharma Sustained Release Excipient Basic Information
Table 87. Allergan Pharma Sustained Release Excipient Product Overview
Table 88. Allergan Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Allergan Business Overview
Table 90. Allergan Recent Developments
Table 91. Janssen Pharmaceuticals Pharma Sustained Release Excipient Basic Information
Table 92. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Overview
Table 93. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Janssen Pharmaceuticals Business Overview
Table 95. Janssen Pharmaceuticals Recent Developments
Table 96. Mayne Pharma Group Pharma Sustained Release Excipient Basic Information
Table 97. Mayne Pharma Group Pharma Sustained Release Excipient Product Overview
Table 98. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mayne Pharma Group Business Overview
Table 100. Mayne Pharma Group Recent Developments
Table 101. BASF Pharma Sustained Release Excipient Basic Information
Table 102. BASF Pharma Sustained Release Excipient Product Overview
Table 103. BASF Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BASF Business Overview
Table 105. BASF Recent Developments
Table 106. International Flavors and Fragrances Pharma Sustained Release Excipient Basic Information
Table 107. International Flavors and Fragrances Pharma Sustained Release Excipient Product Overview
Table 108. International Flavors and Fragrances Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. International Flavors and Fragrances Business Overview
Table 110. International Flavors and Fragrances Recent Developments
Table 111. Ashland Global Pharma Sustained Release Excipient Basic Information
Table 112. Ashland Global Pharma Sustained Release Excipient Product Overview
Table 113. Ashland Global Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ashland Global Business Overview
Table 115. Ashland Global Recent Developments
Table 116. Evonik Industries Pharma Sustained Release Excipient Basic Information
Table 117. Evonik Industries Pharma Sustained Release Excipient Product Overview
Table 118. Evonik Industries Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Evonik Industries Business Overview
Table 120. Evonik Industries Recent Developments
Table 121. Croda International Pharma Sustained Release Excipient Basic Information
Table 122. Croda International Pharma Sustained Release Excipient Product Overview
Table 123. Croda International Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Croda International Business Overview
Table 125. Croda International Recent Developments
Table 126. Gattefosse Pharma Sustained Release Excipient Basic Information
Table 127. Gattefosse Pharma Sustained Release Excipient Product Overview
Table 128. Gattefosse Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Gattefosse Business Overview
Table 130. Gattefosse Recent Developments
Table 131. Merck KGaA Pharma Sustained Release Excipient Basic Information
Table 132. Merck KGaA Pharma Sustained Release Excipient Product Overview
Table 133. Merck KGaA Pharma Sustained Release Excipient Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Merck KGaA Business Overview
Table 135. Merck KGaA Recent Developments
Table 136. Global Pharma Sustained Release Excipient Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Pharma Sustained Release Excipient Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Pharma Sustained Release Excipient Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Pharma Sustained Release Excipient Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Pharma Sustained Release Excipient Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Pharma Sustained Release Excipient Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Pharma Sustained Release Excipient Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Pharma Sustained Release Excipient Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Pharma Sustained Release Excipient Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Pharma Sustained Release Excipient Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Pharma Sustained Release Excipient Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Pharma Sustained Release Excipient Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Pharma Sustained Release Excipient Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Pharma Sustained Release Excipient Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharma Sustained Release Excipient
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharma Sustained Release Excipient Market Size (M USD), 2019-2030
Figure 5. Global Pharma Sustained Release Excipient Market Size (M USD) (2019-2030)
Figure 6. Global Pharma Sustained Release Excipient Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharma Sustained Release Excipient Market Size by Country (M USD)
Figure 11. Pharma Sustained Release Excipient Sales Share by Manufacturers in 2023
Figure 12. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers in 2023
Figure 13. Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharma Sustained Release Excipient Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharma Sustained Release Excipient Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharma Sustained Release Excipient Market Share by Type
Figure 18. Sales Market Share of Pharma Sustained Release Excipient by Type (2019-2024)
Figure 19. Sales Market Share of Pharma Sustained Release Excipient by Type in 2023
Figure 20. Market Size Share of Pharma Sustained Release Excipient by Type (2019-2024)
Figure 21. Market Size Market Share of Pharma Sustained Release Excipient by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharma Sustained Release Excipient Market Share by Application
Figure 24. Global Pharma Sustained Release Excipient Sales Market Share by Application (2019-2024)
Figure 25. Global Pharma Sustained Release Excipient Sales Market Share by Application in 2023
Figure 26. Global Pharma Sustained Release Excipient Market Share by Application (2019-2024)
Figure 27. Global Pharma Sustained Release Excipient Market Share by Application in 2023
Figure 28. Global Pharma Sustained Release Excipient Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharma Sustained Release Excipient Sales Market Share by Region (2019-2024)
Figure 30. North America Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pharma Sustained Release Excipient Sales Market Share by Country in 2023
Figure 32. U.S. Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pharma Sustained Release Excipient Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pharma Sustained Release Excipient Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pharma Sustained Release Excipient Sales Market Share by Country in 2023
Figure 37. Germany Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pharma Sustained Release Excipient Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pharma Sustained Release Excipient Sales Market Share by Region in 2023
Figure 44. China Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pharma Sustained Release Excipient Sales and Growth Rate (Kilotons)
Figure 50. South America Pharma Sustained Release Excipient Sales Market Share by Country in 2023
Figure 51. Brazil Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pharma Sustained Release Excipient Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pharma Sustained Release Excipient Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pharma Sustained Release Excipient Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharma Sustained Release Excipient Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharma Sustained Release Excipient Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharma Sustained Release Excipient Sales Forecast by Application (2025-2030)
Figure 66. Global Pharma Sustained Release Excipient Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pharma Sustained Release Excipient
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharma Sustained Release Excipient Market Size (M USD), 2019-2030
Figure 5. Global Pharma Sustained Release Excipient Market Size (M USD) (2019-2030)
Figure 6. Global Pharma Sustained Release Excipient Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharma Sustained Release Excipient Market Size by Country (M USD)
Figure 11. Pharma Sustained Release Excipient Sales Share by Manufacturers in 2023
Figure 12. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers in 2023
Figure 13. Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharma Sustained Release Excipient Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharma Sustained Release Excipient Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharma Sustained Release Excipient Market Share by Type
Figure 18. Sales Market Share of Pharma Sustained Release Excipient by Type (2019-2024)
Figure 19. Sales Market Share of Pharma Sustained Release Excipient by Type in 2023
Figure 20. Market Size Share of Pharma Sustained Release Excipient by Type (2019-2024)
Figure 21. Market Size Market Share of Pharma Sustained Release Excipient by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharma Sustained Release Excipient Market Share by Application
Figure 24. Global Pharma Sustained Release Excipient Sales Market Share by Application (2019-2024)
Figure 25. Global Pharma Sustained Release Excipient Sales Market Share by Application in 2023
Figure 26. Global Pharma Sustained Release Excipient Market Share by Application (2019-2024)
Figure 27. Global Pharma Sustained Release Excipient Market Share by Application in 2023
Figure 28. Global Pharma Sustained Release Excipient Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharma Sustained Release Excipient Sales Market Share by Region (2019-2024)
Figure 30. North America Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pharma Sustained Release Excipient Sales Market Share by Country in 2023
Figure 32. U.S. Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pharma Sustained Release Excipient Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pharma Sustained Release Excipient Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pharma Sustained Release Excipient Sales Market Share by Country in 2023
Figure 37. Germany Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pharma Sustained Release Excipient Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pharma Sustained Release Excipient Sales Market Share by Region in 2023
Figure 44. China Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pharma Sustained Release Excipient Sales and Growth Rate (Kilotons)
Figure 50. South America Pharma Sustained Release Excipient Sales Market Share by Country in 2023
Figure 51. Brazil Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pharma Sustained Release Excipient Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pharma Sustained Release Excipient Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pharma Sustained Release Excipient Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pharma Sustained Release Excipient Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharma Sustained Release Excipient Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharma Sustained Release Excipient Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharma Sustained Release Excipient Sales Forecast by Application (2025-2030)
Figure 66. Global Pharma Sustained Release Excipient Market Share Forecast by Application (2025-2030)
